PRESS RELEASE published on 11/05/2024 at 06:30, 16 days 7 hours ago Ad hoc announcement pursuant to Art. 53 LR News Release
PRESS RELEASE published on 08/06/2024 at 06:30, 3 months 15 days ago Ad hoc announcement pursuant to Art. 53 LR News Release
BRIEF published on 05/07/2024 at 06:35, 6 months 14 days ago Oerlikon Metco Announces Q1 2024 Financial Results Showing Increased Order Intake and Strong Profitability Financial Results Surface Solutions Q1 2024 Oerlikon Metco Polymer Processing
PRESS RELEASE published on 05/07/2024 at 06:30, 6 months 14 days ago Q1 with Improved Sequential Order Intake in Polymer Processing Solutions and Strong Profitability in Both Divisions OC Oerlikon reports improved sequential order intake in Polymer Processing Solutions and strong profitability in Q1. Surface Solutions maintain stable sales. Guidance for 2024 confirmed 2024 Guidance OC Oerlikon Polymer Processing Solutions Q1 Sequential Order Intake
BRIEF published on 03/21/2024 at 16:35, 7 months 30 days ago Oerlikon Metco Inc. Shareholders Approve All Resolutions at AGM Dividend AGM OC Oerlikon Sustainability Report Board Re-election
PRESS RELEASE published on 03/21/2024 at 16:30, 7 months 30 days ago Shareholders approved all resolutions Shareholders at OC Oerlikon's AGM approved dividend payout, re-elected Prof. Dr. Michael Suess as Chairman, and voted in all Board and HRC members standing for re-election Shareholders Board Members AGM OC Oerlikon Dividend Payout
PRESS RELEASE published on 02/20/2024 at 06:30, 9 months 1 day ago Resilient Operational Results in Highly Demanding Environment; Taking Final Step to Become a Pure-Play Surface Solutions Leader Over Next 12-36 Months Oerlikon announces strategic decision to focus on Surface Solutions, reporting resilient operational results for 2023 while expecting a decrease in sales for 2024. Polymer Processing Solutions impacted 2023 results 2024 Outlook Operational Results Oerlikon Surface Solutions Polymer Processing Solutions
BRIEF published on 02/20/2024 at 06:30, 9 months 1 day ago Oerlikon announces resilient operational results and a strategy focused on surface solutions Business Strategy Dividend Annual Results Oerlikon Surface Solutions
PRESS RELEASE published on 02/08/2024 at 17:30, 9 months 12 days ago Invitation to Oerlikon’s 2023 results analyst and investor conference OC Oerlikon invites analysts and investors to its 2023 results conference with Executive Chairman, Michael Suess, and CFO, Philipp Mueller, providing an update on 2023 results and 2024 outlook 2024 Outlook OC Oerlikon Results Conference Analyst Investor
PRESS RELEASE published on 11/02/2023 at 06:30, 1 year ago Sales and Margins Impacted by Weak End Markets; Focusing on Cost Containment and Strong Technology Pipeline; Long-Term Demand Drivers Intact
Published on 11/21/2024 at 14:00, 12 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 12 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 12 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 42 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 37 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 57 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 14 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 52 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 27 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 27 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo